A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

NCT05094336 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

329

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced MTAP-null Solid Tumors

Interventions

DRUG: Anvumetostat
DRUG: Docetaxel
DRUG: Comparator Anvumetostat Test Tablet

Sponsor

Amgen